GLP-1 medications show little effect on cancer, study shows

A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup